Page last updated: 2024-09-03

rmi 12330a and Alloxan Diabetes

rmi 12330a has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, S; Kim, SH; Oh, YB; Park, WH; Shah, A	1

Other Studies

1 other study(ies) available for rmi 12330a and Alloxan Diabetes

Article	Year
Suppression of ANP secretion by somatostatin through somatostatin receptor type 2. Peptides, 2011, Volume: 32, Issue:6 Topics: Animals; Atrial Function; Atrial Natriuretic Factor; Blotting, Western; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Extracellular Fluid; Heart Atria; Hemodynamics; Imines; Male; Myocardial Contraction; Oligopeptides; Organ Culture Techniques; Peptides, Cyclic; Polymerase Chain Reaction; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Somatostatin; RNA, Messenger; Signal Transduction; Somatostatin	2011

Article

Year

Suppression of ANP secretion by somatostatin through somatostatin receptor type 2.

Peptides, 2011, Volume: 32, Issue:6

Topics: Animals; Atrial Function; Atrial Natriuretic Factor; Blotting, Western; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Extracellular Fluid; Heart Atria; Hemodynamics; Imines; Male; Myocardial Contraction; Oligopeptides; Organ Culture Techniques; Peptides, Cyclic; Polymerase Chain Reaction; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Somatostatin; RNA, Messenger; Signal Transduction; Somatostatin

2011